EV/EBITDA
-5.20
-0.25-5.05%
70 min ago
Summary
- As of March 12, 2025, NRIX EV/EBITDA is -5.20, with a fall of -0.25 (-5.05%) during the most recent trading day.
- NRIX EV/EBITDA is now -340.68% below its all-time high of -1.18.
Performance
NRIX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
NRIX EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | -5.0% | +5.0% | +4.6% |
1 m1 month | +17.1% | -17.1% | -16.0% |
3 m3 months | +30.9% | -30.9% | -29.3% |
6 m6 months | +36.5% | -29.8% | -36.2% |
ytdytd | +24.2% | -24.2% | -22.8% |
1 y1 year | - | - | +1.4% |
5 y5 years | - | - | - |
NRIX EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -7.7% | -6.37 | +18.4% | |
3 m | 3-month | -4.83 | -7.7% | -7.92 | +34.3% |
6 m | 6-month | -4.83 | -7.7% | -10.55 | +50.7% |
1 y | 1-year | -4.83 | -7.7% | -10.55 | +50.7% |
3 y | 3-year | -1.18 | -340.7% | -10.55 | +50.7% |
5 y | 5-year | -1.18 | -340.7% | -29.15 | +82.2% |
alltime | all time | -1.18 | -340.7% | -29.15 | +82.2% |
Nurix Therapeutics EV/EBITDA History
Date | Value |
---|---|
2025 | -5.20(-24.2%) |
2024 | -6.86(+102.4%) |
2023 | -3.39(+26.5%) |
Date | Value |
---|---|
2022 | -2.68(-75.5%) |
2021 | -10.96(-40.6%) |
2020 | -18.45 |
FAQ
- What is Nurix Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Nurix Therapeutics?
- What is NRIX EV/EBITDA year-to-date change?
What is Nurix Therapeutics EV/EBITDA?
The current EV/EBITDA of NRIX is -5.20
What is the all time high EV/EBITDA for Nurix Therapeutics?
Nurix Therapeutics all-time high EV/EBITDA is -1.18
What is NRIX EV/EBITDA year-to-date change?
Nurix Therapeutics EV/EBITDA has changed by +1.66 (+24.20%) since the beginning of the year